186 related articles for article (PubMed ID: 30098214)
1. YY1 binds to the E3' enhancer and inhibits the expression of the immunoglobulin κ gene via epigenetic modifications.
Zhou X; Xian W; Zhang J; Zhu Y; Shao X; Han Y; Qi Y; Ding X; Wang X
Immunology; 2018 Dec; 155(4):491-498. PubMed ID: 30098214
[TBL] [Abstract][Full Text] [Related]
2. The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription.
Zhou X; Xiang Y; Garrard WT
J Immunol; 2010 Dec; 185(12):7544-52. PubMed ID: 21076060
[TBL] [Abstract][Full Text] [Related]
3. A new hypersensitive site, HS10, and the enhancers, E3' and Ed, differentially regulate Igκ gene expression.
Zhou X; Xiang Y; Ding X; Garrard WT
J Immunol; 2012 Mar; 188(6):2722-32. PubMed ID: 22323542
[TBL] [Abstract][Full Text] [Related]
4. E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.
Lazorchak AS; Schlissel MS; Zhuang Y
Mol Cell Biol; 2006 Feb; 26(3):810-21. PubMed ID: 16428437
[TBL] [Abstract][Full Text] [Related]
5. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.
Liu Z; Garrard WT
Mol Cell Biol; 2005 Apr; 25(8):3220-31. PubMed ID: 15798207
[TBL] [Abstract][Full Text] [Related]
6. The Downstream Transcriptional Enhancer, Ed, positively regulates mouse Ig kappa gene expression and somatic hypermutation.
Xiang Y; Garrard WT
J Immunol; 2008 May; 180(10):6725-32. PubMed ID: 18453592
[TBL] [Abstract][Full Text] [Related]
7. A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer.
Roque MC; Smith PA; Blasquez VC
Mol Cell Biol; 1996 Jun; 16(6):3138-55. PubMed ID: 8649425
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Enhancer Marks and Transcription Factor Binding Influence Vκ Gene Rearrangement in Pre-B Cells and Pro-B Cells.
Kleiman E; Loguercio S; Feeney AJ
Front Immunol; 2018; 9():2074. PubMed ID: 30271408
[TBL] [Abstract][Full Text] [Related]
9. The Ig kappa 3'-enhancer triggers gene expression in early B lymphocytes but its activity is enhanced on B cell activation.
Meyer KB; Teh YM; Neuberger MS
Int Immunol; 1996 Oct; 8(10):1561-8. PubMed ID: 8921435
[TBL] [Abstract][Full Text] [Related]
10. Activating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancer.
Pongubala JM; Atchison ML
J Biol Chem; 1995 Apr; 270(17):10304-13. PubMed ID: 7730336
[TBL] [Abstract][Full Text] [Related]
11. YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus.
Pan X; Papasani M; Hao Y; Calamito M; Wei F; Quinn Iii WJ; Basu A; Wang J; Hodawadekar S; Zaprazna K; Liu H; Shi Y; Allman D; Cancro M; Atchison ML
EMBO J; 2013 Apr; 32(8):1168-82. PubMed ID: 23531880
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.
Pongubala JM; Atchison ML
Mol Cell Biol; 1991 Feb; 11(2):1040-7. PubMed ID: 1899281
[TBL] [Abstract][Full Text] [Related]
13. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
Hodawadekar S; Park K; Farrar MA; Atchison ML
J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
[TBL] [Abstract][Full Text] [Related]
14. The 3' enhancer region determines the B/T specificity and pro-B/pre-B specificity of immunoglobulin V kappa-J kappa joining.
Hiramatsu R; Akagi K; Matsuoka M; Sakumi K; Nakamura H; Kingsbury L; David C; Hardy RR; Yamamura K; Sakano H
Cell; 1995 Dec; 83(7):1113-23. PubMed ID: 8548799
[TBL] [Abstract][Full Text] [Related]
15. The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements.
Satyamoorthy K; Park K; Atchison ML; Howe CC
Mol Cell Biol; 1993 Nov; 13(11):6621-8. PubMed ID: 8413258
[TBL] [Abstract][Full Text] [Related]
16. Dynamic Control of Long-Range Genomic Interactions at the Immunoglobulin κ Light-Chain Locus.
Ribeiro de Almeida C; Hendriks RW; Stadhouders R
Adv Immunol; 2015; 128():183-271. PubMed ID: 26477368
[TBL] [Abstract][Full Text] [Related]
17. E2A and CBP/p300 act in synergy to promote chromatin accessibility of the immunoglobulin κ locus.
Sakamoto S; Wakae K; Anzai Y; Murai K; Tamaki N; Miyazaki M; Miyazaki K; Romanow WJ; Ikawa T; Kitamura D; Yanagihara I; Minato N; Murre C; Agata Y
J Immunol; 2012 Jun; 188(11):5547-60. PubMed ID: 22544934
[TBL] [Abstract][Full Text] [Related]
18. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
Park K; Atchison ML
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
[TBL] [Abstract][Full Text] [Related]
19. JNK/AP1 Pathway Regulates MYC Expression and BCR Signaling through Ig Enhancers in Burkitt Lymphoma Cells.
Ding X; Wang X; Zhu X; Zhang J; Zhu Y; Shao X; Zhou X
J Cancer; 2020; 11(3):610-618. PubMed ID: 31942184
[TBL] [Abstract][Full Text] [Related]
20. YY1 Is Required for Germinal Center B Cell Development.
Banerjee A; Sindhava V; Vuyyuru R; Jha V; Hodewadekar S; Manser T; Atchison ML
PLoS One; 2016; 11(5):e0155311. PubMed ID: 27167731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
